🧠 This Week in Immunology: Record Sales, FDA Approvals, and Autoimmune Innovation
Catch the latest headlines shaping immunology—from groundbreaking trials to major industry moves.
🔍 What’s Inside This Week’s Immunology Briefing:
📈 Galderma Shines with Record Q1 Sales and Blockbuster Launches
🧴 LEO Pharma’s DELTA FORCE Study Sets New Standard for Chronic Hand Eczema in The Lancet
✨ AVAVA™ Earns FDA Clearance for Innovative Acne Scar Treatment
🤝 Genentech and Repertoire Ink $765M Deal to Advance Autoimmune Discovery
🥂 Sebela’s Tegoprazan Outperforms PPIs in GERD Clinical Trials
🚨 Equillium Faces FDA Setback Over Itolizumab for Acute GVHD
💰 AbbVie Lifts 2025 Outlook Following Skyrizi and Rinvoq Sales Surge
📢 Stay Ahead in Immunology Research!
✅ Like, share, and subscribe for weekly updates on immunology breakthroughs and clinical innovations
#ImmunologyUpdates #PharmaNews #AutoimmuneResearch #FDAApprovals #ClinicalTrials #BiotechInnovation #DermatologyNews #HealthcareConsulting #LucidQuest #Galderma #LEOPharma #Genentech #Sebela #AbbVie #Equillium